AI assistant
Sending…
Anika Therapeutics, Inc. — Director's Dealing 2012
Mar 20, 2012
33997_dirs_2012-03-20_24a16f64-00b1-4315-a2a8-6e79358ef214.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANIKA THERAPEUTICS INC (ANIK)
CIK: 0000898437
Period of Report: 2012-03-19
Reporting Person: LAND RAYMOND J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-19 | Common Stock | S | 1000 | $12.132 | Disposed | 21659 | Direct |
| 2012-03-19 | Common Stock | S | 1500 | $11.917 | Disposed | 20159 | Direct |
More from Anika Therapeutics, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 18